Trading Penny Stocks can Chage Your Life

Hello Everyone!

I hope everyone is having a great day so far.

Trading Penny Stocks Can Change Your Life

What is a Penny Stock


A Penny Stock is usually described as a stock less than $5.00 per share, but most of them that we will be involved with are below $2.00.
Invest in Penny Stocks?

Why

The answer to this is simple: (1) They are Volatile. (2) They are HEAVILY Promoted. (3) Profits are HUGE!


Google (GOOG) is currently at $580.00 per share. Do you think it is easier for a $580 stock to double or a .05 cent stock to double? Of course it is the .05 cent stock. These gains occur Every Single Day that the Market is open. Every day stocks are traded there are Penny Stocks that Double. I have NEVER seen a stock over $100 double in a day! Once again; this is a daily occurrance with Penny Stocks. Now that you know this; you have to know which ones are about to move. You need the Pre-Premoted Stocks, the ones that are about to be promoted by several promoters in the same day.



The Question is which ones and How do I get in BEFORE they Double?



That is the Question of the Century. You can spend days, months or however long you desire to research them, but this really will not help you much in picking the ones that move in ONE DAY. That my friends is the way that myself and many others make Good Money each and every day. The KEY is to know what others do NOT know prior to when they discover the news. You must be Positioned in the stock prior to the CROWDS that will follow and that is how you make the Big Bucks Consistently. You can subscribe to all the Free Newsletters and Alerts, but you still will not be on the "Inside". You have to be Positioned in the Stock BEFORE all of these newsletters email there daily alerts. Let me tell you that it is a good feeling to know that you have the inside scoop and know that Tens of Thousands of Emails will be sent out Promoting (Advertising) the stock that you already OWN! There is no better Feeling. What you are about to learn could dramtically change your life. IF, and that is a Big IF, you chose to act on it. You gain nothing in life sitting on the sidelines doing nothing; as the Garth Brooks song goes "Standing Outside the Fire". You need to be in it to Win it!




How do I discover stocks that move up as much as 100% or higher in a day?




I personally subscribe to a variety of Promoters and a variety of people have the "Inside Scoop" to purchasing stocks prior to the crowd---so to speak. It really helps if you receive information an entire day before it is distributed freely to Tens of Thousands of Subscribers to FREE Alerts and Newsletters. You have to Get the News Before the News. If you don't know the News, Prior to the Major Release of the News, you could lose a lot of money and will be holding a stock you don't want to be holding...you were essentially forced to hold or forced to sell for a big loss. These are the ones that usually; after the trading day are holding the bag....in the trading world they are called "Bag Holders" because they missed the boat and did not sell soon enough; so essentially they are stuck. Have you ever been in this situation? I have but I have Learned Sooo Much and it is not only what you know but who you know or who you are associated with. At the end of this blog you will have the opportunity to be associated with the same people I am; and may I say it is WELL WORTH IT!!!



How do I prevent myself from being a "Bag Holder"?



It is really simple. You subscribe to Pay Subscriptions VS Free Newsletters. There are literally thousands of new traders each and ever day that sign up on these FREE Alert Newsletters and what they don't know is that they receive the Trading Alearts "LATE", so all of the Paid Subscribers to Stock Trading Alerts are already positioned in that particular stock that the Freebies are just now receiving .



What does this mean?



It means that you can count on a lot them investing to make you money...so you can easily sell your shares for a profit. The Volume will be high in case you have made a high purchase of let's say 50,000 shares----pending on specific price of stock.....Let's say that the stock is at .01 cents; then selling 50,000 shares after the Free FREEBIE Alerts should be justified.



Do You Desire to Make Consistent Money Everyday Trading Penny Stocks?



If you desire to consistently make 10%---20%---sometimes over 100% in one day, yes that is stocks that Double in a Day; you HAVE to PAY for the Real Time Alerts. You must have the information BEFORE everyone else! I personally have done my research and have the best ones that will make you money! Actually I have more to come for you that I have heard are GREAT ones also.



Have you ever heard this famous saying: "Buy the Rumor and Sell the News" This is exactly the type of information you will have access to . In fact in many cases you receive the Real Time Penny Stock Alerts before the actual companies release the news; not to mention before the Freebies receive their alerts....by this time you should have easily found a position in this particular stock or in many cases stocks.



What do you do from here? You first wait for the all of the Free Penny Stock Alerts to come out; usually released After Hours of a trading day. Second you wait for the company to release "Positive News"---How do I know this will occur? Because I have been doing this for over Ten Years and know the pattern. The Promoters of the particular stock already Know that the company is realeasing News; not only do they know, they know exactly what the news is and when it will be released, that is why you Paid for these alerts....to get in BEFORE the release of positive news. The news is sometimes released prior to market open and sometimes it is released about an hour or two after the market has opened....to put "Gas on the Fire" so to speak to increase purchasing of the stock. I hope you all are understanding the absolute importance of what I am saying here.



Why should I pay for a Subscription to receive Stock Alerts? Many of them in REAL TIME!


Because MOST do not! You will be "Inside the Fire". You will be invested prior to all of those who do not pay and there are tens of thousands and in some cases according to my research Hundreds of Thousands that receive these Free Stock Alerts...and many of them invest.





Have you ever heard of the saying "There is No Business Like Show Business?" I have developed my own saying: "There is No Business Like Your Own Business!" Why do I say this? Because once you begin you will essentially own your own business.



Now I want to talk a little bit about "PROFIT TAKING". This is Very Important.


How do I know when to sell a stock?


Well; assuming you have Paid for a Subscription and you are now ready to recieve information only a privileged few have you need a Trading PLAN. Some subscriptions will give you entry and exit strategies; but it is wise to have always have your own plan and strategy for each trade.


Before you make any trade do this:

(1) Make sure you have a plan. I write mine down most of the time.

A. Know what your target is. Can be price or percentage..but ALWAYS have a target price in mind; especially for day trades; which in this case will be Most of the trades you will receive.

B. Know if you are you in for a day, a week, a month, 3 months or longer.

C. Are you in for specific % gain. If this is the case have a trailing stop in place for about 1/2 of what your target % gain is. I personally am very content with a 10% to 15% gain per trade. **Remember: Banks only pay about 2% a year and you should be making 10% a trade! ***Remember this: DON'T GET GREEDY!!! Trading these stocks are Volatile and can go down even faster than they go up. As I briefly stated above I usually trade once the news is released when the volume is HIGH, so I can liquidate my position easily. ****TIP: Make trades that are easy to liquidate; for example, I usually purchase 5,000 to 15,000 shares. Why? Because MM's (Market Makers) usually trade between 2,500 shares and 5,000 shares at a time. So make it easy to sell in a hurry. Quick trades are usually Good trades; when trading on news and escalating volume.

D. Are you a Volume player. If so study the history of Volume and on a rally when Vol slows the PPS decreases...that is an indicator to get out.

(2) Ask yourself some questions:

A. Can you afford to lose 50% of your investment and be comfortable with this? If not; decrease amount of investment because this is a penny and all penny's are volatile. Sometimes a penny stock goes down so quickly that there is no way your trailing stop will be guaranteed.

B. What am I going to do if the stock retracts 50% from my investment and I don‘t have a stop? Am I going to sell, hold, or accumulate?

C. What if the PPS goes up? What % am I going to sell...what is my goal for investing in this stock. As stated above my target is between 10% and 15% a trade...DO NOT GET GREEDY! BIG TIP: Once I purchase a stock I most frequently place a Sell Stop Order for 10% below purchase price. For example: Let's say I purchased 100 Shares of Stock ABC for .50 cents a share....I would immediately place a Stop Sell Order for .45 cents per share. Just in case the stock does not go up as speculated. There is NEVER a SURE BET. Yes, sometimes even with a heavily promoted stock it will head down; BUT in my case as I have done this for over Ten Years, almost 90% of the ones I have the inside scoop I will make $$$ on. Who can say that; besides the Smart Ones who have Paid for a Quality Paid Trading Alert Subscription?

(3) Know why you invested in this particular stock and this will definitely aid in answering the above q's.
A. Am I investing due to the inside expected Promotion or the expected hype that this particular stock is supposed to receive? If so you are a momentum player; so be at your pc and know how to play it. Price can go up fast but down much faster! ***HUGE TIP: I Personally am in most of my trades for Less Than 3 Hours and many Less than 20 Minutes. But this is how you make the Quick Profits, the Quick Cash. This all depends on the information you recieve from your Paid Stock Subscription Alerts and also what your Pre-Target Profit Percentage is; as talked about previously.

B. Am I investing because I believe in this company's objectives and am willing to give them my hard earned money to help them grow? If so;you have done your DD and have established a high degree of confidence in the company not the company's PPS. Yes, pps is what will ultimately make you money, but knowing your company and management is mandatory. This is generally for a longer term investment; mainly more than a week, not a day trade. Sometimes you will receive long term Stock Pick Trading Alerts from you Paid Stock Subscriptions.

(4) Do NOT invest on Emotion. Emotion will hinder all of your plans on why you originally made the investment and before you know it you are confounded, and most likely will make a mistake(s).

(5) Know how much to invest: How? Depends on if you are in for long term or short term. Obviously short term you will need to know your expected volume and if you will be able to immediately liquidate---You should get an indication from expected promotions. Long term: you can invest more and can liquidate periodically.

The main point is to have a Plan on every trade you make and eventually this will become habitual. Learn from your mistakes; I personally write mine down so I don't forget them because in the past I found myself making the same damn mistakes repeatedly...and by all means I make them every trade in some way, shape or form. You very seldom make a perfect trade, but if you take the time and reflect you will become a better trader. A Perfect Day Trade would be buying at it's lowest price per share and selling at it's highest price per share. I have only done this once in my trading career! So if you do this; you are LUCKY!


If one part of your plan goes wrong it can have the domino effect and just mess every other aspect of it. So have a Plan B if Plan A goes array.



How Do I Get Started Trading Penny Stocks and Making Consistent PROFITS?


Getting Started: How should I begin once I begin receiving my Stock Trading Alerts from my Paid Subscription(s)?


Well; my advice is not to invest at first. Do some Paper Trades---Place what you were thinking on a peice of paper and see how it goes. Follow you plan as your plan will become habitual. You can learn a lot by observing for a week or two and see how it all works. I guarantee you it will be FUN and EXCITING!



ARE YOU READY???


Ok, Are You Ready? Some of the Quality Paid Subscription Trading Alert Sites are listed below: My Advice is to do your personal DD (Due Diligence) on all of them and pick one that you believe would fit you best. You are sooo close to being on your way to Financial Freedom; but you cannot do it standing on the sidelines. ***Remember it is really not What you Know, but more Importantly WHO YOU KNOW! Here is YOUR chance.


P.S. If you need information on my favorite Trading Site that provides a great service and is a heck of a lot less expensive than Etrade or Ameritrade or Even ScotTrade....then send me an email at jdlinke@yahoo.com with "Trading Site Information" and ask your question and I will reply with this valuable information that will save you BIG $$$!



P.S.S. You owe it to YOURSELF to at the very LEAST look through these as they WILL make you money. Be on the Winning side of a Trade. You have no excuse, all the information you need to be successful is here...and then some. Once you are successful and get a rhythm to making these winning trades, choose another one. Each one provides you with a variety of unique trading alert opportunities. Once you purchase and begin trading send me an email if you have any questions regarding how to trade your alerts at jdlinke@yahoo.com and I will inform you more how I trade alerts. Just don't get Greedy and over Zealous as this is what will burn you. One step at a time and you will have more money in your account than you can imagine. Take it slow at first and re-read this blog a few times on taking the 10% to 15% profits. You can; No, You WILL do it! Congrats.

_________________________________________________________________________________


#1. How a College Dropout Turned $1,000 into $1 Million. Trade Alerts that make you money; Guaranteed! Try it; if you don't like it get your money back, but I have a strong feeling that it could pay for itself within the first couple of trades..even for beginners!
How a College Dropout Turned $1,000 into $1 Million. This can be accomplished with less than 100 Trades. Get his Alerts Now! A Must have for ALL Penny Investors…get on the inside

_________________________________________________________________________________





#2. ***L@@K at the Testimonials; just because this is listed second doesn't mean it isn't my favorite. Penny Alerts you cannot Survive without! Watch the Videos. A LIFETIME MEMBERSHIP on this one that you very possibly could or "should" make double on your first trade..to pay for a lifetime Alert membership. These PRE-News Alerts are invaluable!
Roys Best Penny Alerts. Get in before the Crowds

________________________________________________________________________________


#3. ***CHECK OUT THIS GUYS ETRADE ACCOUNT! Go with the Flow...Discover the stocks that will fly. Scroll to the Bottom of the Page to see Etrade Account. Read the Testimonials. Are you Ready??
Go with the Flow!

________________________________________________________________________________





Do You Have a Website? Are you receiving a lot of Unique Visitors Traffic every day? No, you say? Then take a look at this.



Attract Customers to your Web Site in 15 Minutes..If you are having problems with your Blog or Website then this is for you.
Click Here!



_________________________________________________________________________________

If your computer is not running like it was when you first purchased it, you have Registry Problems. Can it be fixed? Yes. Should I think about buying a new computer? Absolutely NOT!
Slow Computer? Read this; it is a fix. Never buy a new computer because the one you have now is running slow; there is no reason why it cannot run the way it did from the very First Day you opened it from the Box! Click Here!



Here are some more Subscriptions to review: Coming Soon as I am evaluating, analyzing and reviewing..stay tuned. More info coming as I am trying some out for a month or two.


If you are dealing with Penny Stocks it is very difficult to be successful on your own. Remember this; if nothing else, "It's not what you know, but more importantly WHO you know!" You now have some great leads to get your butt started making good money every single trading day. Good Luck to you and Great Trading!

Check out our other Posts:
1. Why Buy GNVC?
2. Expect GNVC to head to $3 to $5.
3. Trading Penny Stocks Can Change Your Life
4. Is Kraig Biocraft Laboratories (KBLB) Worth Buying?

Why Buy GNVC??

Attract Customers to your Web Site in 15 Minutes..If you are having problems with your Blog or Website then this is for you.
Click Here!

GenVec, Inc (GNVC) a biopharm with an experienced management team that is currently in Phase III trials with it's potential Blockbuster drug TNFerade for inoperable pancreas cancer -- (Pancreatic Cancer).

GenVec's stock (GNVC) has gone nuts since the news release of the awaiting184th event along with buying pressure from a Cancer Conference in Florida relative to their lead drug candidate for MULTIPLE cancers, but focusing on Esophageal Cancer at the Symposium. The stock price has gone from $1.00 to $3.34 in less than a month; actually the past two weeks! Everyone saw what happened with Dendreon (DNDN) when their Phase III trial was a success; its stock went from $4.00 to over $22.00 in a week! That is over 5 times your money. If you had invested $4,000 at $4.00 a share you could have pocketed a cool $18,000 in a week. Why am I saying this? Because GNVC displays similar attributes. IF TNFerade Phase III trials are successful you can count on GNVC absolutely flying just as DNDN did. There has been a buzz about GenVec for the past six months and it was just a matter of time before the price took off as it did last week--people are so zealous they can hardly wait for the results. I boldy believe that this may only the beginning if TNFerade's Phase III trial is successful. Results from phase II started the buzz. Investors along with Mutual Funds and Institutions have this pivotal Phase III on their radars. It may be worth it to just purchase a100 shares after observing the aftershock of DNDN's stock. GNVC has a pipeline that is quite impressive as you may read later on here which eases the "downside" and this strong pipeline acts as a reinforcement and leads to the justification on taking a shot at this one.

I wouldn't be surprised if GNVC attempted to raise some funds. Why? Because now would be the absolute perfect time while the stock has been nothing but going up for 3 weeks and they need funds to continue with the Variety of studies they are in the process of which you will see below...great pipeline and TNFerade may be successful in Multiple forms of cancers. The potential is there for a Mega Blockbuster for the various treatments that TNFerade could provide. Just pancreas cancer would be a Blockbuster....Blockbuster is defined in the stock world having a $Billion potential.

*****UPDATE: GNVC announced that it is going to raise capitol of $28 million at $2.00 per share; exercisable at $2.75. http://finance.yahoo.com/news/GenVec-Announces-Registered-prnews-4197154088.html?x=0&.v=1

Insiders Not Selling GNVC

You can often get a feeling about a stocks future success by observing insider selling. GNVC insiders have not been selling so far; so in my opinion they are just as excited as the investors! In 2010 there have been no reported selling.





SEE FULL CHART BELOW ON BOTTOM OF PAGE:

It is estimated that about 40,000 new cases of Pancreatic Cancer will be diagnosed in 2010. The overall survival rate after 5 years is only about 5%. So 95% of pancreas cancer patients will die within 5 years. Do you see why GNVC is getting all the attention right now? The current treatments for Pancreatic Cancer are not working.

Pancreas Cancer is the fourth leading cause of cancer related deaths. Pancreatic Cancer accounts for about 2% of ALL the costs of caring for cancer patients. It is estimated that well over $1 Billion will be spent in 2010.

Today January 26, 2010 GNVC finally had a down day. The stock closed at $2.47 down .19 cents or 7.14% today. The low of the month was $1.23 and that was the first trading day of 2010, January 4th. The high so far this month is $3.34, yesterday January 25, 10. It will be very interesting watching this stock for the next month as more and more take a position; just to be in it to have a chance of another DNDN.

t is expected that GNVC will have statistics regarding this pivoting Phase III trial of TNFerade next month; February 2010. Stay tuned! GNVC has a pretty alluring pipeline also; so it's not a "one trick pony" so to speak. Read my personal notes below to learn a LOT more about the HUGE potential of GNVC. The sleeping Giant has awakened!
**Plus GNVC has just signed an agreement with Novartis.

Slow Computer? Read this it is a fix. Never buy a new computer because it is running slow; there is no reason why it cannot run the way it did from the very First Day you opened it from the Box!
Click Here!



Here is a copy of my personal "diary" of my notes from GNVC, if interested.
GNVC--GenVec, Inc. **Potential to easily double from October 5, 2009! If TNFerade is shows a good survival rate. EPS= -.266 cents. Market Cap: $79 Million. Market Cap as of October 13, 2009 is $104 Million. Outstanding Shares=106.2 Million shares. Average Volume is 1.5 Million Shares traded each day. Institutional Ownership: 12%. Short Interest: 9%.
Results expected in 1Q 2010...so stock price will rise at first of year. They have a HUGE Pipeline and excellent potential.

Stock Price as of June 1st, 2009 is ($0.72) Stock Price as of October 6th, 2009 is $.79 cents. Stock Price as of October 13, 2009 is $.98 cents.
I purchased this stock at .75 cents, then sold at $1.00

From Yahoo Finance:
GenVec, Inc., a clinical stage biopharmaceutical company, develops gene-based therapeutic drugs and vaccines in the United States. Its lead therapeutic product candidate, TNFerade biologic, is under Phase III trial for first-line treatment of inoperable, locally advanced pancreatic cancer. The company is also evaluating TNFerade for the treatment of various cancers, including esophageal cancer, rectal cancer, and head and neck cancer.

GenVec is also developing TherAtoh, a preclinical program involving the delivery of the human atonal gene for the production of therapeutic proteins by cells in the inner ear. Further, GenVec uses its proprietary adenovector technology to develop vaccines for infectious diseases, including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus, and HSV-2. It has strategic alliances and research contracts with the U.S. department of homeland security, the U.S. department of agriculture, PATH’S malaria vaccine initiative, the U.S. naval medical research center, and the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The company was founded in 1992 and is based in Gaithersburg, Maryland.

Sources for information for information below.
This is a great article that describes a lot of what you need to know about GNVC.
Article regarding head and neck cancer.

Below: This explains the PACT trial. PACT study) with TNFerade[TM] in patients with locally advanced pancreatic cancer: On January 3, 2008 these 2 changes were agreed upon with the FDA and GenVec

* (1) Measure overall survival as the primary efficacy endpoint, rather than 12-month survival. No increase in study size will be required, and a benefit in overall survival can be considered as a basis for full regulatory approval of TNFerade for this indication;

* (2) Conduct two additional interim analyses of overall survival following one-third (92) and two-thirds (184) of the total events (deaths) for the study, with the potential to stop the trial if there is clear evidence of the drug's efficacy. The two interim analyses will be performed with minimal statistical penalties of 0.001
There is a total of 330 patients with 220 of them to receive TNFerade plus Chemo and Radiation and the other 110 to receive only the standard care of Chemotherapy plus Radiation.

GenVec, Inc announced that overall survival data in locally advanced pancreatic cancer patients treated with TNFerade in GenVec's ongoing Phase 3 Pancreatic Cancer Clinical Trial with TNFerade (PACT) were presented at ASCO. **Comment 10-29-09: I believe this is after 92 Deaths; so there would be 238 living. The analysis concluded that TNFerade appeared to be safe and well-tolerated, indicating a 25% reduction in the risk of death in the TNFerade plus standard-of-care (SOC) arm compared to the patients receiving SOC alone. In the SOC patients, 75% of the patients died within approximately 11.8 months. However, in the TNFerade plus SOC group, 75% of the patients did not die until approximately 19.4 months. GenVec's PACT trial is a multi-center, randomized, active, and controlled study of 330 patients designed to evaluate the safety and efficacy of TNFerade plus standard of care versus standard of care alone in patients with locally advanced pancreatic cancer. The next interim analysis is expected to occur after two-thirds of the events (or 184 deaths) have occurred in the trial. Results are expected to be announced in early 2010.

Aug. 28, 2009 just read this on post on ARNA board that this stock has potential in 2010. Stock Price on August 28, 2009 is $.7556 which was down a penny today or 1.83%. Stock Price on September 15, 2009 is $.84 cents up .05 cents today. This company is developing a drug called TNFerade for Pancreatic Cancer and they say it could have other benefits in treating Rectal Cancer. They also have a FMD vaccine agreement with the FDA. ******Potential Doubler in one year from now…meaning within the next year, one year from today August 28, 2009 I believe this stock will double from .75 cents to $1.50, sometime within this year. Update: September 15, 2009---Evidently the news is supposed to come out soon, so this stock will move one way or the other here shortly…need to research more, all I know is that Pancreatic Cancer is in need of new drugs, unfortunately the ones that I am studying all deal with survival rates, so in order to get a drug out they have to complete trials in which the majority of peopled die and I don’t think that is the correct incentive for a drug company; I mean they are only focusing on creating drugs that will mildly increase survival by a six months or so.
**Update: January 24, 2010: GNVC is over $3.00

The below information is from
http://www.istockanalyst.com/article/viewarticle/articleid/3468585

Pancreatic cancer is the lead indication for TNFerade™. They are conducting a 330-patient randomized, controlled Phase III clinical trial (the PACT study) designed to assess the safety and clinical benefit of using TNFerade™ in combination with standard of care treatment in patients with locally advanced pancreatic cancer. They are expected to be completed by Q1 2010.

Positive Results from Phase II Trials

29 patients were treated at University of California Irvine Comprehensive Digestive Disease Center between 1/2003 and 11/2008; 20 patients with TNF + SOC and 9 patients with SOC. In the TNF + SOC treated group mean age was 64.8 (range 50-80); 15 male; 12 tumors were Stage II, 8 Stage III. In the SOC treated group mean age was 65.9 (range 52-84); 5 male; 6 tumors were Stage II, 3 Stage III. Kaplan-Meier survival analysis showed the overall median survival was 14.7 months in the TNF + SOC treated group and 11.1 months in the SOC treated group. Conclusions In patients treated at a single institution in two similar trial settings, TNF + SOC resulted in a median survival of 14.7 months vs. 11.1 months for patients receiving only SOC. These results are encouraging and are consistent with results across both multi center trials that show a trend towards improvement in survival following the addition of TNFerade Biologic to SOC.

Recent developpment. The analysis concluded that TNFerade appeared to be safe and well-tolerated. The analysis also indicated a 25% reduction in the risk of death in the TNFerade plus standard-of-care (SOC) arm compared to the patients receiving SOC alone (Hazard Ratio = 0.75; 95% Confidence Interval [0.494 - 1.15]).

Dr. Mark Thornton, GenVec's Senior Vice President of Product Development commented on the poster, noting, "In the SOC patients, 75% of the patients died within approximately 11.8 months. However, in the TNFerade plus SOC group, 75% of the patients did not die until approximately 19.4 months. Although the data still need time and events to reach maturity, we are encouraged by the survival trend being observed at this point in the trial."

TherAtoh Atonal therapy is a product concept to restore hearing or balance function through the regeneration of critical cells of the inner ear. Hearing and balance require specialized cells of the inner ear called sensory hair cells. During embryonic development a gene termed atonal (ATOH) induces the generation of these cells. GenVec has shown preclinically that the production of the ATOH protein results in the formation of new inner ear sensory hair cells, and the restoration of hearing and balance function.

There are currently no effective treatments available for patients who have lost all balance function, and hearing loss remains a major unmet medical problem.

The market potential for this product is truly mammoth, as the cost of medical care for patients with balance disorders has been estimated to exceed $1 billion per year.

Vaccines

HIV Vaccine

In collaboration with the Vaccine Research Center/National Institute of Allergy and Infectious Diseases/National Institutes of Health, GenVec is developing a vaccine candidate to protect against the three most common types of HIV-1 virus found around the world, clades A, B and C. The vaccine candidate utilizes GenVec's proprietary adenovector delivery technology and 293-ORF6 production cell line and is designed to generate a broad spectrum of immune responses including neutralizing antibodies and cytolytic T cell immunity characteristic of the most effective vaccines.

The Vaccine Research Center is managing the clinical development of this program. The vaccine candidate (VRC-HIVADV014-00VP) is being evaluated alone and in combination with a plasmid DNA vaccine prime. In October 2005, the VRC announced the initiation of Phase II testing for this vaccine candidate. In addition, six Phase I trials have completed enrollment with more than 150 healthy participants having received the adenovector vaccine candidate.

Vaccine Research Funding Worth $50M

In 2004, GenVec announced an expanded collaboration to include the development of a second-generation vaccine candidate. This program is being funded through a subcontract managed and administered by SAIC-Frederick, Inc. worth up to $50 million.

Penny Alerts you cannot Survive without! Check this website out, do some DD.
Roys Best Penny Alerts. Get in before the Crowds



Malaria Vaccine

In collaboration with the Naval Medical Research Center (NMRC), and with additional research support from the Malaria Vaccine Initiative (MVI), GenVec is developing multi-antigen vaccine candidates, produced using GenVec's proprietary 293-ORF6 cell line, designed to attack both the blood and liver stages of malaria, a complex parasitic disease. The intention is to generate a broad spectrum of immune responses including neutralizing antibodies and cytolytic T cell immunity, characteristic of the most effective vaccines. This approach toward eliciting a broad spectrum immune response and attacking multiple stages of the life cycle has shown promise in pre-clinical animal models.

In January 2007, the NMRC initiated Phase I testing of a vaccine candidate jointly developed with GenVec at its clinical trials center. The first phase of this study is designed to evaluate the safety and immunogenicity of two doses of the vaccine candidate in healthy volunteers. After safety evaluation and confirmation of the optimal dose, the second (challenge) phase of the study will evaluate the protective effects of the vaccine following exposure to malaria. The ability to safety challenge human volunteers provides a unique opportunity for assessing the efficacy of candidate vaccines prior to the initiation of field trials.

How a College Dropout Turned $1,000 into $1 Million. Trade Alerts that make you money; Guaranteed! Try it; if you don't like it get your money back, but I have a strong feeling that it could pay for itself within the first couple of trades..even for beginners!
How a College Dropout Turned $1,000 into $1 Million. This can be accomplished with less than 100 Trades. Get his Alerts Now! A Must have for ALL Penny Investors…get on the inside


Foot and Mouth Disease

In collaboration with the U.S. Department of Homeland Security and the U.S. Department of Agriculture (USDA)-Agricultural Research Service (ARS), GenVec is developing candidate vaccines and anti-viral agents to prevent the spread of FMD. FMD has been identified as a key potential threat to the U.S. economy and the country's food supply, whether infection were to occur as a result of bioterrorism or by accidental exposure to the disease.

In studies with DHS, ARS and GenVec, GenVec's proprietary adenovector system and cell line was utilized to safely produce, for the first time on the U.S. mainland, an effective FMD vaccine. Preliminary testing by DHS scientists has shown that this vaccine candidate effectively prevented clinical disease (symptoms) in cattle when they were challenged with the FMD virus. Results from these challenge studies were reported on November 11, 2005, at the 8th National Meeting and 1st International Meeting of Researchers of the Livestock Sciences by Marvin Grubman, Ph.D., USDA-ARS, Plum Island Animal Disease Center, who conceived and developed this vaccine approach. The DHS Targeted Advanced Development group at Plum Island Animal Disease Center, led by Laszlo Zsak, D.V.M., Ph.D., is also collaborating with ARS and GenVec in the development of the vaccine.

In addition, anti-viral candidates are being developed to prevent the spread of FMD from the time an outbreak occurs until the vaccine has generated a sufficient immune response to protect the animal.

Without a marked vaccine that can be safely manufactured in the U.S., options for responding to an FMD outbreak in the U.S. are more limited. The curtailment of meat and meat products for domestic supply and the stoppage of meat exports would have severe economic consequences. For example, in its January 2003 Final Report as required by the Animal Disease Risk Assessment, Prevention and Control Act of 2001, the USDA's Inter-Agency Working Group notes that the 2001 outbreak of FMD in the United Kingdom resulted in the slaughter of some 4 million animals and a loss to the British economy of between $3.6 and $11.6 billion. The report also notes that U.S. exports of cattle, sheep, hogs, and many of their products varies annually from $6 to $10 billion, that many of these exports would face restrictions during an FMD outbreak, and that if even one area of one state was affected by FMD, trade restrictions would be imposed on the nation as a whole, at least during the initial stage of the outbreak.



Experienced Management & Board of Directors

GenVec truly stands apart from other biotechs simply due to its well-rounded and experienced management team. Paul H. Fischer, Ph.D. has served as President and Chief Executive Officer and as a director of Genvec, Inc. since 1996. Prior to joining GenVec, he was Executive Vice President of Research and Development with Oncologix, Inc. (now Antigenics, Inc.), a biotechnology company. Previous experience included Manager, Cancer Research at Pfizer, Inc., a pharmaceutical company. Dr. Fischer received his B.S. in Biology from the University of Denver, his Ph.D. in Pharmacology from the University of California at San Francisco and performed post-doctoral research in Pharmacology at Yale University School of Medicine and was an associate Professor of Human Oncology at the University of Wisconsin.

Now if the CEO's Pharmacology post-doctral research at one of America's top unversities, Yale, is not enough to instill confidence in you, take a look at the rest of the company's celebrated and accomplished individuals at the helm. For a list of GenVec’s Officers and Directors go here "http://www.reuters.com/finance/stocks/officerProfile?symbol=GNVC.O&officerId=166993"http://www.reuters.com/finance/stocks/officerProfile?symbol=GNVC.O&officerId=166993

Financial Analysis

GenVec ended the second quarter of 2009 with $12.6 million in cash and investments. ( source )

"Based on existing contracts and collaborations, we anticipate revenues for 2009 will be between $15.0 million and $18.0 million. We project our cash burn to be between $8.0 million and $11.0 million for the 12 months ending June 30, 2010," commented Douglas J. Swirsky, GenVec's Senior Vice President and Chief Financial Officer. "In spite of the difficult economic times, GenVec continues to make strides in its therapeutic and vaccine programs. We look forward to sharing additional data from our pivotal trial in locally-advanced pancreatic cancer early next year."
Additionally, GenVec was one of the few companies within the biotech industry to receive the maximum Buy Rating from Reuter's Analyst Recommendation System.



Major Institutional and Mutual Fund Holders

GenVec ranks among the best of any companies we have ever profiled when it comes to attracting institutional and mutual fund investors. This represents a very bullish forward looking guidance, as these high profile investors usual infuse large cash amounts with each trade. Here is a breakdown from Yahoo Finance of the major players which are heavily invested.

Number of Institutions Holding Shares: 36
% of Shares Held by Institutional & Mutual Fund Owners: 13%

Now if you've been around the investments niche for quite some time now, you know that whenever 36 institutions are holding a company, this represents a major bullish signal and a company with a lot of future potential. However, if you're an expert like our Founder, and Lead Investment Analyst, these figures aren't impressive unless you know who exactly these mutual funds and institutions are. Well, lets take a look:

When you are in the company of Vanguard, Barclays, Bank of America Corp., Spartan and Royce Micro, just to name a few, there is no better feeling than being a part of a stable and profitable investment.

Overall Sentiment

Expect prices to rise back to the $1.50 – $2.00 levels as investors become more aware of the deep pipeline being offered by GenVec. *Update: As they have last week!

Surrounded by cash infusions through grants, mutual and institutional investors, multi-purpose products with billion dollar market potential, and an already flowing revenue stream – GenVec is one company you shouldn't pass by.

When analyzing the future guidance of GenVec, all you need to do is remind yourself of the story on Dendreon Corporation, and how the results on TFNerade's Phase III during Q1 2010 will affect the price.

TNFerade Treatments for Pancreatic cancer (Fast Track FDA Designation), possible treatments in head and neck cancer, esophageal cancer, and rectal cancer. Add Vaccines for HIV, Malaria, and Foot and Mouth Disease to that list and one thing is clear – The potential for GenVec is truly astronomical.



#1. How a College Dropout Turned $1,000 into $1 Million. Trade Alerts that make you money; Guaranteed! Try it; if you don't like it get your money back, but I have a strong feeling that it could pay for itself within the first couple of trades..even for beginners!
How a College Dropout Turned $1,000 into $1 Million. This can be accomplished with less than 100 Trades. Get his Alerts Now! A Must have for ALL Penny Investors…get on the inside

#2. Penny Alerts you cannot Survive without!
Roys Best Penny Alerts. Get in before the Crowds

#3. Go with the Flow...Discover the stocks that will fly!
Go with the Flow!

Attract Customers to your Web Site in 15 Minutes..If you are having problems with your Blog or Website then this is for you.
Click Here!

Slow Computer? Read this it is a fix. Never buy a new computer because it is running slow; there is no reason why it cannot run the way it did from the very First Day you opened it from the Box!
Click Here!

To put it bluntly here: There are ample reasons to think about investing in GenVec. The hype has arrived and isn't going away. There may be some dips in the next few weeks that will present some good entry points for those of you who are new to GenVec.

*One last note: Investing in any pharmaceutical can be extremely risky; especially after the price has risen like it has the past few weeks. I believe the downside is not unlimited as with many pharmaceuticals that have only one drug---GNVC has an extensive pipeline that can produce high revenues in the future. Do some DD on GNVC!
GLTYA!!!

Chart of Insiders Not Selling GNVC
Go here to see Full Chart Please and to see Insider Purchases.